These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22502692)

  • 1. Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer.
    Turk HM; Camci C; Sevinc A; Bukyukberber S; Sari I; Adli M
    Asian Pac J Cancer Prev; 2012; 13(1):315-8. PubMed ID: 22502692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy.
    Shimizu K; Yukawa T; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
    World J Surg Oncol; 2015 Feb; 13():21. PubMed ID: 25888998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma.
    Matsumura Y; Umemura S; Ishii G; Tsuta K; Matsumoto S; Aokage K; Hishida T; Yoshida J; Ohe Y; Suzuki H; Ochiai A; Goto K; Nagai K; Tsuchihara K
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2159-70. PubMed ID: 25989941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
    Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
    Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Lung Cancer Mortality in a Referral Center.
    Jamaati H; Baghaei P; Sharifianfard M; Emami H; Najmi K; Seifi S; Salimi B; Pourabdollah M; Kiani A; Hashemian M; Khosravi A
    Asian Pac J Cancer Prev; 2016; 17(6):2877-81. PubMed ID: 27356706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups.
    Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W
    PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
    Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
    J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
    Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
    Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.
    Kim GY; Lim SJ; Kim YW
    Mod Pathol; 2011 Oct; 24(10):1336-47. PubMed ID: 21572400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.
    Laga AC; Zander DS; Cagle PT
    Arch Pathol Lab Med; 2005 Sep; 129(9):1113-7. PubMed ID: 16119982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
    Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
    J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer survival in Norway, 1997-2011: from nihilism to optimism.
    Nilssen Y; Strand TE; Fjellbirkeland L; Bartnes K; Møller B
    Eur Respir J; 2016 Jan; 47(1):275-87. PubMed ID: 26541525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma.
    Khaksar E; Askarishahi M; Hekmatimoghaddam S; Vahedian-Ardakani H
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3389-3393. PubMed ID: 29286608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.